| Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia SO Ciurea, MJ Zhang, AA Bacigalupo, A Bashey, FR Appelbaum, ... Blood, The Journal of the American Society of Hematology 126 (8), 1033-1040, 2015 | 664 | 2015 |
| Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen–matched unrelated and … A Di Stasi, DR Milton, LM Poon, A Hamdi, G Rondon, J Chen, SR Pingali, ... Biology of Blood and Marrow Transplantation 20 (12), 1975-1981, 2014 | 256 | 2014 |
| Treatment options for triple-class refractory multiple myeloma J Mikhael Clinical Lymphoma Myeloma and Leukemia 20 (1), 1-7, 2020 | 93 | 2020 |
| Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation C Ustun, JAH Young, GA Papanicolaou, S Kim, KW Ahn, M Chen, ... Bone marrow transplantation 54 (8), 1254-1265, 2019 | 57 | 2019 |
| Emergence of chronic myelogenous leukemia from a background of myeloproliferative disorder: JAK2V617F as a potential risk factor for BCR-ABL translocation SRK Pingali, MA Mathiason, SD Lovrich, RS Go Clinical Lymphoma and Myeloma 9 (5), E25-E29, 2009 | 47 | 2009 |
| Prevention of cytomegalovirus reactivation in haploidentical stem cell transplantation AE Hammerstrom, LR Lombardi, SR Pingali, G Rondon, J Chen, ... Biology of Blood and Marrow Transplantation 24 (2), 353-358, 2018 | 46 | 2018 |
| Complete local and Abscopal responses from a combination of radiation and Nivolumab in refractory Hodgkin's lymphoma Q Qin, X Nan, T Miller, R Fisher, B Teh, S Pandita, AM Farach, SR Pingali, ... Radiation research 190 (3), 322-329, 2018 | 38 | 2018 |
| MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma Q Wang, D Zhao, M Xian, Z Wang, E Bi, P Su, J Qian, X Ma, M Yang, L Liu, ... Blood, The Journal of the American Society of Hematology 136 (22), 2557-2573, 2020 | 36 | 2020 |
| Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis–a retrospective study from a tertiary center X Nan, Q Qin, C Gentille, J Ensor, C Leveque, SR Pingali, AT Phan, ... Leukemia & Lymphoma 58 (9), 2110-2117, 2017 | 36 | 2017 |
| Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission SR Pingali, SW Jewell, L Havlat, MA Bast, JR Thompson, DC Eastwood, ... Cancer 120 (14), 2122-2129, 2014 | 35 | 2014 |
| Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors K Anand, G Sahu, E Burns, A Ensor, J Ensor, SR Pingali, V Subbiah, ... ESMO open 5 (4), e000866, 2020 | 34 | 2020 |
| T-cell lymphoma secondary to checkpoint inhibitor therapy K Anand, J Ensor, SR Pingali, P Hwu, M Duvic, S Chiang, R Miranda, ... Journal for immunotherapy of cancer 8 (1), 2020 | 30 | 2020 |
| Pushing the envelope—nonmyeloablative and reduced intensity preparative regimens for allogeneic hematopoietic transplantation SR Pingali, RE Champlin Bone marrow transplantation 50 (9), 1157-1167, 2015 | 30 | 2015 |
| Current concepts of clinical management of multiple myeloma SR Pingali, RY Haddad, A Saad Disease-a-Month 58 (4), 195-207, 2012 | 29 | 2012 |
| G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg? JG Youssef, F Zahiruddin, G Youssef, S Padmanabhan, J Ensor, ... Annals of hematology 100, 667-673, 2021 | 26 | 2021 |
| Mycobacterial infections with ruxolitinib: a retrospective pharmacovigilance review K Anand, EA Burns, J Ensor, L Rice, SR Pingali Clinical Lymphoma Myeloma and Leukemia 20 (1), 18-23, 2020 | 24 | 2020 |
| Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant … Y Inamoto, I Petriček, L Burns, S Chhabra, Z DeFilipp, P Hematti, A Rovó, ... Bone marrow transplantation 54 (5), 648-661, 2019 | 23 | 2019 |
| Cardiotoxicity associated with anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy: recognition, risk factors, and management EA Burns, C Gentille, B Trachtenberg, SR Pingali, K Anand Diseases 9 (1), 20, 2021 | 22 | 2021 |
| Disparities in the diagnosis of hypertrophic obstructive cardiomyopathy: a narrative review of current literature J Burns, P Jean-Pierre Cardiology Research and Practice 2018, 2018 | 22 | 2018 |
| High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison … Y Nieto, BC Valdez, SR Pingali, R Bassett, R Delgado, J Nguyen, N Shah, ... The Lancet Haematology 4 (6), e283-e292, 2017 | 22 | 2017 |
